In this episode, Darcy Wooten, MD, discusses new HIV data from IDWeek 2021, including:
- A rapid test-and-treat program to start DTG/3TC in patients newly diagnosed with HIV (STAT)
- Efficacy when switching from 3-drug to 4-drug TAF-based regimens to DTG/3TC (TANGO)
- Virologic outcomes with 2-drug vs 3-drug ART regimens (Trio Health HIV Network Study)
- Metabolic complications in treatment-naive patients (Study 1489 and Study 1490)
- Resistance analysis of an investigational agent, lenacapavir (CALIBRATE)
- The Positive Perspectives Survey to evaluate the U=U Educational Campaign in North American patients
Presenter:
Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California
Link to full program:
https://bit.ly/3BCHF2E